Gandhinagar

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specialisations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialisation in Medical Devices.

The Early-Career Fellowship Programme demands outstanding academic track record with limited opportunities for the year 2021. While the expectation from the candidates is very high, the Institute is committed to providing necessary support along with a conducive environment to achieve the goals.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

The National Innovation Foundation (NIF) India, is India's national initiative to strengthen the grassroots technological innovations and outstanding traditional knowledge. Its mission is to help India become a creative and knowledge-based society by expanding policy and institutional space for grassroots technological innovators.  NIF scouts, supports and spawns' grassroots innovations developed by individuals and local communities in any technological field, helping in human survival without any help from formal sector.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.